+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID05730036

Study Comparing Linvoseltamab to Elotuzumab, Pomalidomide, and Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma

Led by Regeneron Pharmaceuticals · Updated on 2026-10-07

410

Participants Needed

159

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating an experimental drug called linvoseltamab REGN5458 in adults with relapsed or refractory multiple myeloma who have received one to four prior treatments and still have standard treatment options available. This study compares linvoseltamab to a combination of three cancer drugs elotuzumab, pomalidomide, and dexamethasone EPd. The goal is to assess the safety and effectiveness of linvoseltamab versus EPd, including how long participants benefit and the impact on their disease and symptoms. Participants are randomly assigned to receive either linvoseltamab given by intravenous infusion or the combination of elotuzumab IV infusion, pomalidomide oral capsules, and dexamethasone oral tablets or IV infusion. Half the participants receive linvoseltamab, and the other half receive the EPd combination. Treatments are monitored over time to evaluate responses and side effects. During the study, participants will have regular assessments including disease evaluations based on established criteria, pain assessments using the Brief Pain Inventory, and quality of life questionnaires. Researchers will track progression-free survival, overall survival, treatment responses, side effects, and other health measures for up to approximately five years. This includes monitoring blood levels of the study drug and immune responses. The total study duration extends to the primary completion date in 2033.

CONDITIONS

Brief Title

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

Research Team

C

Clinical Trials Administrator

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here